RIBOMETRIX
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Feb 2024)
What this means for you
This application is over — abandoned 19 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88730272
- Mark type
- Stylized text
- Filed
- 17 Dec 2019
- Published for opposition
- 24 Nov 2020
- Abandoned
- 19 Feb 2024
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of neurodegenerative diseases, cancer, HIV, hematopoietic disease and disorders, blood disorders, cardiovascular diseases and disorders, genetic diseases and disorders, liver diseases and disorders, infectious diseases, immune system related diseases and disorders, metabolic diseases and disorders, kidney diseases and disorders, and reproductive diseases and disorders; pharmaceutical preparations comprised of small molecules in the nature of organic compounds that target RNA for use in medical treatments via the induction or inhibition of gene expression; pharmaceutical preparations that contain RNA-targeting small molecule therapeutics for the treatment of neurodegenerative diseases, cancer, HIV, hematopoietic disease and disorders, blood disorders, cardiovascular diseases and disorders, genetic diseases and disorders, liver diseases and disorders, infectious diseases, immune system related diseases and disorders, metabolic diseases and disorders, kidney diseases and disorders, and reproductive diseases and disorders
- Class 042 — Scientific and technological services: research and development services in the field of pharmaceuticals
Owner
- Ribometrix, Inc., Durham, NC, US
- Ribometrix, Inc., Durham, NC, US
Prosecution history
- 20 Feb 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Feb 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Nov 2023 — ASSIGNED TO EXAMINER
- 29 Jun 2023 — ASSIGNED TO EXAMINER
- 08 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jun 2023 — SOU EXTENSION 5 GRANTED
- 31 May 2023 — SOU EXTENSION 5 FILED
- 07 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 May 2023 — SOU TEAS EXTENSION RECEIVED
- 20 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2022 — SOU EXTENSION 4 GRANTED
- 16 Dec 2022 — SOU EXTENSION 4 FILED
- 16 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2022 — SOU EXTENSION 3 GRANTED